Showing 1-50 of 913 stocks
| Number | Ticker | Industry | Market Cap | Last Price | Change % | Volume |
|---|---|---|---|---|---|---|
| 1 | LLYEli Lilly and Company | Biotechnology: Pharmaceutical Preparations | $818.6B | $938.95 | -1.77% | 1.4M |
| 2 | JNJJohnson & Johnson | Biotechnology: Pharmaceutical Preparations | $589.2B | $238.06 | -1.17% | 4.6M |
| 3 | ABBVAbbVie Inc. | Biotechnology: Pharmaceutical Preparations | $375.7B | $208.20 | -1.97% | 2.8M |
| 4 | AZNAstraZeneca PLC | Biotechnology: Pharmaceutical Preparations | $316.4B | $204.23 | -0.34% | 1.3M |
| 5 | NVSNovartis AG | Biotechnology: Pharmaceutical Preparations | $286.9B | $154.10 | -0.61% | 613.1K |
| 6 | UNHUnitedHealth Group | Medical Specialities | $279.3B | $304.74 | -0.81% | 3.8M |
| 7 | MRKMerck & Company Inc. (new) | Biotechnology: Pharmaceutical Preparations | $268.7B | $121.53 | -1.12% | 6.2M |
| 8 | PMPhilip Morris International Inc | Medicinal Chemicals and Botanical Products | $249.9B | $160.15 | -0.86% | 3.3M |
| 9 | AMGNAmgen Inc. | Biotechnology: Biological Products (No Diagnostic Substances) | $188.0B | $350.85 | -1.32% | 1.3M |
| 10 | ABTAbbott Laboratories | Medical/Dental Instruments | $183.3B | $100.13 | -2.42% | 8.7M |
| 11 | GILDGilead Sciences Inc. | Biotechnology: Biological Products (No Diagnostic Substances) | $173.9B | $138.88 | -2.29% | 2.6M |
| 12 | NVONovo Nordisk A/S | Biotechnology: Biological Products (No Diagnostic Substances) | $166.1B | $37.52 | +0.23% | 9.6M |
| 13 | ISRGIntuitive Surgical Inc. | Medical/Dental Instruments | $160.8B | $450.43 | -1.06% | 981.7K |
| 14 | PFEPfizer Inc. | Biotechnology: Pharmaceutical Preparations | $155.2B | $26.90 | -1.18% | 20.8M |
| 15 | MDTMedtronic plc. | Biotechnology: Electromedical & Electrotherapeutic Apparatus | $131.9B | $87.10 | -0.95% | 6.3M |
| 16 | BTIBritish American Tobacco Industries p.l.c. ADR | Medicinal Chemicals and Botanical Products | $130.6B | $58.82 | -0.08% | 3.2M |
| 17 | SYKStryker Corporation | Medical/Dental Instruments | $127.0B | $339.36 | +0.19% | 1.4M |
| 18 | BMYBristol-Myers Squibb Company | Biotechnology: Pharmaceutical Preparations | $123.7B | $58.56 | -1.50% | 5.9M |
| 19 | MOAltria Group Inc. | Medicinal Chemicals and Botanical Products | $107.8B | $67.29 | -0.33% | 4.7M |
| 20 | SNYSanofi ADS | Biotechnology: Pharmaceutical Preparations | $107.3B | $46.76 | -0.60% | 2.1M |
| 21 | MCKMcKesson Corporation | Other Pharmaceuticals | $106.8B | $866.51 | -0.77% | 446.8K |
| 22 | HCAHCA Healthcare Inc. | Hospital/Nursing Management | $105.5B | $494.93 | -2.42% | 472.7K |
| 23 | GSKGSK plc (Each representing two) | Biotechnology: Pharmaceutical Preparations | $96.1B | $58.24 | -0.07% | 3.8M |
| 24 | BSXBoston Scientific Corporation | Medical/Dental Instruments | $93.4B | $61.68 | +0.60% | 9.8M |
| 25 | REGNRegeneron Pharmaceuticals Inc. | Biotechnology: Pharmaceutical Preparations | $77.5B | $748.87 | -2.40% | 503.0K |
| 26 | ELVElevance Health Inc. | Medical Specialities | $76.5B | $312.01 | -1.79% | 588.4K |
| 27 | MMM3M Company | Medical/Dental Instruments | $76.4B | $150.10 | -0.19% | 1.2M |
| 28 | CIThe Cigna Group | Medical Specialities | $69.3B | $271.78 | -2.29% | 624.5K |
| 29 | CORCencora Inc. | Other Pharmaceuticals | $68.5B | $320.74 | -0.48% | 773.6K |
| 30 | IDXXIDEXX Laboratories Inc. | Biotechnology: In Vitro & In Vivo Diagnostic Substances | $57.1B | $563.31 | -3.72% | 348.7K |
| 31 | TAKTakeda Pharmaceutical Company Limited (each representing 1/2 of a share of) | Biotechnology: Pharmaceutical Preparations | $56.6B | $18.09 | -1.99% | 2.4M |
| 32 | BDXBecton Dickinson and Company | Medical/Dental Instruments | $51.5B | $153.90 | -1.06% | 1.5M |
| 33 | EWEdwards Lifesciences Corporation | Industrial Specialties | $50.2B | $77.72 | -1.71% | 3.6M |
| 34 | CAHCardinal Health Inc. | Other Pharmaceuticals | $50.0B | $215.00 | -0.71% | 954.2K |
| 35 | ZTSZoetis Inc. | Biotechnology: Pharmaceutical Preparations | $48.7B | $117.62 | -1.89% | 1.5M |
| 36 | ARGXargenx SE | Biotechnology: Biological Products (No Diagnostic Substances) | $42.9B | $799.38 | -0.12% | 266.7K |
| 37 | ALNYAlnylam Pharmaceuticals Inc. | Biotechnology: Pharmaceutical Preparations | $42.1B | $322.18 | +0.34% | 529.7K |
| 38 | MDLNMedline Inc. Class A Common Stock | Medical/Dental Instruments | $37.0B | $45.56 | +0.00% | 3.6M |
| 39 | ALCAlcon Inc. | Ophthalmic Goods | $35.9B | $78.01 | +0.79% | 1.2M |
| 40 | RMDResMed Inc. | Medical/Dental Instruments | $33.6B | $228.80 | +0.53% | 333.1K |
| 41 | TEVATeva Pharmaceutical Industries Limited | Biotechnology: Pharmaceutical Preparations | $33.5B | $30.79 | -0.31% | 3.3M |
| 42 | ONCBeiGene Ltd. American Depositary Shares | Biotechnology: Pharmaceutical Preparations | $31.4B | $309.60 | +0.00% | 100.3K |
| 43 | INSMInsmed Incorporated | Biotechnology: Pharmaceutical Preparations | $30.1B | $154.43 | -2.94% | 1.4M |
| 44 | IQVIQVIA Holdings Inc. | Biotechnology: Commercial Physical & Biological Resarch | $28.6B | $167.30 | -0.99% | 1.0M |
| 45 | NTRANatera Inc. | Medical Specialities | $28.0B | $192.58 | -5.10% | 2.5M |
| 46 | BIIBBiogen Inc. | Biotechnology: Pharmaceutical Preparations | $27.1B | $172.92 | -2.30% | 740.1K |
| 47 | DXCMDexCom Inc. | Medical/Dental Instruments | $26.5B | $63.93 | -2.78% | 1.4M |
| 48 | PHGKoninklijke Philips N.V. NY Registry Shares | Medical Electronics | $26.1B | $28.32 | +0.60% | 611.3K |
| 49 | UTHRUnited Therapeutics Corporation | Biotechnology: Pharmaceutical Preparations | $25.1B | $571.23 | -0.62% | 262.8K |
| 50 | BNTXBioNTech SE | Biotechnology: Biological Products (No Diagnostic Substances) | $24.2B | $95.63 | +4.22% | 776.4K |
This page provides a comprehensive list of stocks in the Health Care sector. The data includes market capitalization, current prices, price changes, trading volume, and industry classification.
Disclaimer: The information provided on this page is for informational purposes only and should not be considered as financial advice. Stock prices and market data are subject to change. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.